from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3819/-

LFCtreatmentdescriptionclass of inhibitor

-0.812

Amikacinug/mL Amikacintranslation

-1.548

Cap5-10ug/mL Capreomycintranslation

-1.567

Rox10-50 ug/mL Roxithromycintranslation

-0.127

SM2-5 ug/mL Streptomycintranslation

-0.316

Tet5-10 ug/mL Tetracyclinetranslation

-1.686

Rif0.2-5ug/mL Rifampicintranscription

0.246

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.139

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.733

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.240

CPZ10-50 ug/mL Chlorpromazinerespiration

2.048

Clofazimine10-13 ug/mL Clofaziminerespiration

0.953

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.994

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.362

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.059

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.214

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.707

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.058

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.668

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.508

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.256

KCN5-20 ug/mL Potassium cyaniderespiration

0.785

NaN30.2-2 mM Sodium aziderespiration

0.380

Nigericin50 uM Nigericinrespiration

0.607

TRC10-150 ug/mL Triclosanrespiration

1.098

TRZ10-25 ug/mL Thioridazinerespiration

-0.435

Valinomycin0.5-10 uM Valinomycinrespiration

-0.333

ZnSO42 mM ZnSO4respiration

0.140

menadione6-10 ug/mL Menadionerespiration

0.372

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.138

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.363

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.313

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.595

NRP_1Non-replicating persistence stage 1dosRassociated

0.324

Amp0.2mg/mL AmpicillincellWall

-0.262

Cephalexin20-100 ug/mL CephalexincellWall

-0.012

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.433

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.267

EMB10-20 ug/mL EthambutolcellWall

-0.171

Eta12-40 ug/mL EthionamidecellWall

-0.695

INH0.2-0.4 ug/mL IsoniazidcellWall

0.479

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.104

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.462

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.119

BZA0.12 mg/mL BenzamidearomaticAmides

-0.488

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.813

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.472

H2O24 mM hydrogen peroxideDNAdamaging

0.167

Levo10 ug/mL LevofloxacinDNAdamaging

-0.255

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.178

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.296

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.336

UVUV-irradiationDNAdamaging

-0.958

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.954

Antimycin12.5-50 ug/mL Antimycin A?

0.285

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.788

PA_110-50 ug/mL Antitubercular compound PA-1?

0.639

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.764

PA8240.2-2 ug/mL PA-824?

-1.046

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-1.015

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.912

Verapamil50 uM Verapamil?

-0.037

mercaptoethanol2 mM 2-Mercaptoethanol?

0.088

methoxatin10-20 ug/mL Methoxatin?